CLDX - Celldex Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue9,53812,7436,7865,480
Cost of Revenue65,44996,171102,026100,171
Gross Profit-55,911-83,428-95,240-94,691
Operating Expenses
Research Development66,44966,44966,44966,449
Selling General and Administrative19,26925,00333,57933,837
Non Recurring----
Others----
Total Operating Expenses84,942122,070136,602135,021
Operating Income or Loss-75,404-109,327-129,816-129,541
Income from Continuing Operations
Total Other Income/Expenses Net-76,545-7,9861,2862,344
Earnings Before Interest and Taxes-75,404-109,327-129,816-129,541
Interest Expense----
Income Before Tax-151,949-117,313-128,530-127,197
Income Tax Expense-765-24,282--
Minority Interest----
Net Income From Continuing Ops-151,184-93,031-128,530-127,197
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-151,184-93,031-128,530-127,197
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-151,184-93,031-128,530-127,197